News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Galea Life Sciences'. BioSource Therapeutics, Inc. Subsidiary Submits Clinical Policy Abstract to 17th International AIDS Conference



2/7/2008 11:24:11 AM

MIAMI, Feb. 7, 2008 (PRIME NEWSWIRE) -- Galea Life Sciences, Inc. (Pink Sheets:GLSN) announces that its wholly owned subsidiary, BioSource Therapeutics, Inc. (BST), has submitted its clinical policy abstract to AIDS 2008 -- the 17th International AIDS Conference -- being held August 3-8, 2008 in Mexico City. BST is the maker of Nutraplete Therapeutic Drink Mix, the first dietary supplement product designed specifically for people living with HIV/AIDS.

Read at GlobeNewswire


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES